Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Blopress

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Blopress was produced by Takeda.

Takeda CEO admits to Blopress mis-marketing

Takeda CEO admits to Blopress mis-marketing

Hasegawa told the Wall Street Journal that the company had used a graph in promotional literature indicating Blopress (candesartan cilexetil) was more effective than rival blood pressure drug Norvasc (amlodipine) from ... Blopress - also sold as Atacand -

Takeda rides out Actos decline as fiscal 2012 sales rise

Takeda rides out Actos decline as fiscal 2012 sales rise steep decline for antihypertensive Blopress (candesartan), also on generic competition, which ended the year down 22 per cent to 169bn yen. ... The drug's US launch is due in the summer. Azilva also contributed to Takeda's domestic sales growth on the

Country report: The healthcare market in Japan

Country report: The healthcare market in Japan Aricept. donepezil. Eisai. Alzheimer's disease. 2. Blopress. candesartan. Takeda. Hypertension. 3.

EU approval for Takeda's once-daily hypertension drug Edarbi

Takeda's own candesartan cilexetil (marketed as Amias and Blopress in Europe), which made $2.8bn last year.

A rush for sweet success

DysportTM (Medicis). Glabellar lines. US. Candesartan cilexetil/hydrochlorothiazide. Blopress Plus (Takeda). Essential hypertension.

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Pandemic preparedness
The pandemic preparedness paradox
Why our efficient ‘just in time’ mentality must be replaced with a resilient ‘just in case’ activity...
Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...

Infographics